Patent · US Active

Long-acting prodrugs of entecavir, preparing methods and uses thereof

US11292811B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2018
Grant dateApr 5, 2022
Priority date
Expiry dateSep 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are a long-acting prodrug of Entecavir, preparation method and use thereof, wherein the prodrug of Entecavir has a structure of formula I. The prodrug of Entecavir can be released slowly, sustainably and steady, and converted to active compound of Entecavir to achieve a long-acting effect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.